Abstract:P32 protein serves as a crucial structural component of Goat pox virus (GTPV), which causes a highly virulent infectious disease in sheep and goats. Despite the fact that P32 has been widely expressed in the previous studies, it is difficult to obtain recombinant P32 efficiently. This study aimed to achieve soluble expression of P32 recombinant protein and to develop its specific monoclonal antibody. The gene fragment of P32Δ (GP32Δ) was synthesized by optimizing the coding sequence of amino acids 1-246 of the known goatpox P32 protein. Subsequently, GP32Δ was cloned into a prokaryotic expression vector for expression and purification, resulting in the successful production of soluble recombinant protein rP32Δ. Utilizing rP32Δ, an indirect ELISA method was established by immunizing 6-week-old BALB/c mice with inactivated GTPV as the antigen. Through hybridoma technology, three monoclonal antibody hybridoma cell lines secreting anti-goat pox virus rP32Δ were screened, designated as 2F3, 3E8, and 4H5, respectively. These monoclonal antibodies, classified as IgG1, IgG2a, and IgG2b, respectively, with κappa light chains, were characterized following ascites preparation and purification. Indirect ELISA results demonstrated that the ELISA potency of the three monoclonal antibodies exceeded 1:12800. Furthermore, Western blot analysis revealed specific reactivity of both 3E8 and 4H5 with rP32Δ, while immunofluorescence assays confirmed 3E8's ability to specifically recognize GTPV in cells. The preceding findings demonstrate the successful acquisition of the soluble expressed recombinant P32 protein and its specific monoclonal antibody 3E8 in this study, thereby laying a foundational material basis for the establishment of a GTPV detection method.

Prokaryotic Expression and Purification of Gag Protein of Enzootic Nasal Tumor Virus of Goats and Preparation of Its Polyclonal Antibody

[Preparation of a Monoclonal Antibody Against Polyhedrin of Ectropis Obliqua Nucleopolyhedrovirus].

Cell Surface Display of Rabies Virus Glycoprotein by Using Ice Nucleation Protein

Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS

Prokaryotic Expression of GP5 of PRRSV and Analysis of Its Immunoreactivity

Expression of goat poxvirus P32 protein and monoclonal antibody preparation

Development of in-house ELISA based on recombinant gag proteins of small ruminant lentiviruses isolated from goats in Thailand

Molecular cloning and expression of rgpA and rgpB proteinase region genes of Porphyromonas gingivalis

Preparation and Identification of Polyclonal Antibodies of GGPPS

Expression and Purification of Hog Cholera Lapinised Virus Erns Gene in Escherichia coli

Prokaryotic Expression of Structural Domains of the Newcastle Disease Virus Hemagglutinin-Neuraminidase

Expression and purification of human PrP-like protein Shadoo and preparation of antibody against Shadoo

Prokaryotic cell expression of the surface antigen 1 gene from GJS strain of Toxoplasma gondii and its antigenicity analysis

Prokaryotic Expression,Purification and Identification of Rabies Virus Glycoprotein Extracellular Domain Gene

[Expression and purification of rabies virus glycoprotein and analysis of its specific binding capacity to memory B cells]

High-level Expression of Nucleoprotein Gene of Rabies Virus in Escherichia Coli

Prokaryotic Expression and Purification of HIV-1 Vif and Hapobec3g, Preparation of Polyclonal Antibodies

Soluble Expression and Purification of Bluetongue Virus Type 1 (BTV1) Structure Protein VP2 in Escherichia Coli and Its Immunogenicity in Mice

Prokaryotic Expression and Priliminary Evaluation of the Immunization Efficacy of Varicella-Zoster Virus Glycoprotein E

Stakeholder Governance, Competition and Firm Value

[Acute undifferentiated leukemia: two cases report].